NCT04307615 O2 Versus CPAP Treatment of Patients Undergoing SIPE Therapy (OCTOPUS)
| NCT ID | NCT04307615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dalarna County Council, Sweden |
| Condition | Swimming Induced Pulmonary Edema (SIPE) |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2022-07-02 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2022-07-02 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In swimming induced pulmonary edema (SIPE), there is a lack of knowledge regarding optimal treatment. The present study was designed to assess the benefit of continuous positive airway pressure (CPAP) compared to oxygen as a first line treatment of SIPE in the out-of-hospital environment.
Eligibility Criteria
Inclusion Criteria: * clinical diagnosis of swimming induced pulmonary edema (SIPE) with need of acute treatment (oxygen saturation ≤91%) * 18 years and older * informed consent Exclusion Criteria: * declined consent * suspected acute coronary syndrome * severe asthma diagnosed together with pulmonary edema where beta-agonist-inhalation is needed prior to treatment of pulmonary edema * hemodynamic instability or decreased consciousness
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04307615 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Swimming Induced Pulmonary Edema (SIPE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04307615 currently recruiting?
Yes, NCT04307615 is actively recruiting participants. Contact the research team at maria.hardstedt@regiondalarna.se for enrollment information.
Where is the NCT04307615 trial being conducted?
This trial is being conducted at Falun, Sweden.
Who is sponsoring the NCT04307615 clinical trial?
NCT04307615 is sponsored by Dalarna County Council, Sweden. The trial plans to enroll 90 participants.